Skip to main content
PRECISION BIOSCIENCES INC logo

PRECISION BIOSCIENCES INC — Investor Relations & Filings

Ticker · DTIL ISIN · US74019P2074 LEI · 549300I5QGRS3BLHZH41 US Professional, scientific and technical activities
Filings indexed 542 across all filing types
Latest filing 2025-08-06 Major Shareholding Noti…
Country US United States of America
Listing US DTIL

About PRECISION BIOSCIENCES INC

https://precisionbiosciences.com/

Precision BioSciences is a clinical-stage gene editing company focused on developing therapeutic candidates using its proprietary ARCUS® genome editing platform. ARCUS is a novel technology that utilizes sequence-specific DNA-cutting enzymes, or nucleases, to perform targeted edits within living cells and tissues. The platform is designed to insert (knock-in), remove (knock-out), or repair DNA sequences. The company's primary application of this technology is the development of in vivo gene editing therapies aimed at overcoming and potentially curing rare genetic diseases and other hard-to-treat conditions.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-06 English
8-K
Regulatory Filings
2025-08-06 English
FORM 4
Director's Dealing
2025-07-08 English
Regulatory Filings 2025
Regulatory Filings
2025-07-03 English
FORM 4
Director's Dealing
2025-06-27 English
FORM 4
Director's Dealing
2025-06-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.